Security key
464288836
- Type / Class
- Equity / U.S. PHARMA ETF
- Total 13F shares
- 4,719,905
- Share change
- -195,581
- Total reported value
- $342,421,380
- Price per share
- $72.56
- Number of holders
- 150
- Value change
- -$13,835,896
- Number of buys
- 50
- Number of sells
- 50
Report period
Q3 2025
Institutions
150
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 464288836
Recent filing periods:
Top shareholders of IHE - ISHARES TR - U.S. PHARMA ETF (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2025
As of 30 Sep 2025,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,719,905 shares.
The largest 10 holders included
Fisher Asset Management, LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, JPMORGAN CHASE & CO, ROYAL BANK OF CANADA, BNP PARIBAS FINANCIAL MARKETS, BROWN ADVISORY INC, and RAYMOND JAMES FINANCIAL INC.
This page lists
150
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
140
Q3 2025 holders
150
Holder diff
10
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.